Similarly, fibulin-3 inhibition decreased IL-1β in the tumor cells (Fig. 2C) but IL-1β in the host (mouse) was unchanged or increased (Fig. 1C; Supplementary Fig. S7), indicating additional cell sources for this proinflammatory cytokine in the tumor (49). Here, IL1B is linked to neoplasm.